{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:21:35Z","timestamp":1740122495121,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11239-017-1577-y","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T15:06:04Z","timestamp":1509721564000},"page":"192-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A sticky situation: myocardial infarction in a young woman with immune thrombocytopenia on eltrombopag and a history of mediastinal radiation"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-5772","authenticated-orcid":false,"given":"Jennifer","family":"Teichman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Taher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Hashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Bagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Sholzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"1577_CR1","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117:4190\u20134207","journal-title":"Blood"},{"key":"1577_CR2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12185-015-1837-6","volume":"102","author":"D Cines","year":"2015","unstructured":"Cines D, Gernsheimer T, Wasser J et al (2015) Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim. Int J Hematol 102:259\u2013270","journal-title":"Int J Hematol"},{"key":"1577_CR3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.medcli.2015.03.014","volume":"145","author":"F Catal\u00e1-Lopez","year":"2015","unstructured":"Catal\u00e1-Lopez F, Corrales I, de la Fuente-Honrubia C et al (2015) Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials. Med Clin 145:511\u2013519","journal-title":"Med Clin"},{"key":"1577_CR4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood.V116.21.70.70","volume":"116","author":"JB Bussel","year":"2010","unstructured":"Bussel JB, Cheng G, Saleh M et al (2010) Incidence of thromboembolic events across eltrombopag clinical trials In chronic immune thrombocytopenia (ITP). Blood 116:70","journal-title":"Blood"},{"key":"1577_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4274\/tjh.2016.0169","volume":"34","author":"S Sert","year":"2017","unstructured":"Sert S, Ozdil H, Sunbul M (2017) Acute myocardial infarction due to eltrombopag therapy in a patient with immune thrombocytopenic purpura. Turkish J Hematol 34:107\u2013108","journal-title":"Turkish J Hematol"},{"key":"1577_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2174\/1574886311207040255","volume":"11","author":"H Gunes","year":"2016","unstructured":"Gunes H, Kivrak T (2016) Eltrombopag induced thrombosis: a case with acute myocardial infarction. Curr Drug Saf 11:174\u2013176","journal-title":"Curr Drug Saf"},{"key":"1577_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/2325957414557266","volume":"14","author":"M Kowalczyk","year":"2015","unstructured":"Kowalczyk M, Rubinstein PG, Aboulafia DM (2015) Initial experience with the use of thrombopoetin receptor agonists in patients with refractory HIV-associated immune thrombocytopenic purpura: a case series. J Int Assoc Provid AIDS Care 14:211\u2013216","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"1577_CR8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s40264-015-0337-1","volume":"38","author":"TTL Nguyen","year":"2015","unstructured":"Nguyen TTL, Palmaro A, Montastruc F et al (2015) Signal for thrombosis with eltrombopag and romiplostim: a disproportionality analysis of spontaneous reports within VigiBase. Drug Saf 38:1179\u20131186","journal-title":"Drug Saf"},{"key":"1577_CR9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1538-7836.2009.03584.x","volume":"8","author":"S Chu","year":"2010","unstructured":"Chu S, Becker R, Berger P et al (2010) Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 8:148\u2013156","journal-title":"J Thromb Haemost"},{"key":"1577_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00277-011-1249-5","volume":"91","author":"J Haselboeck","year":"2012","unstructured":"Haselboeck J, Pabinger I, Cihan A et al (2012) Platelet activation and function during eltrombopag treatment in immune thrombocytopenia. Ann Hematol 91:109\u2013113","journal-title":"Ann Hematol"},{"key":"1577_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1160\/TH13-10-0873","volume":"112","author":"M Alvarez Rom\u00e1n","year":"2014","unstructured":"Alvarez Rom\u00e1n M, Fern\u00e1ndez Bello I, Arias-Salgado E et al (2014) Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia. Thromb Haemost 112:65\u201372","journal-title":"Thromb Haemost"},{"key":"1577_CR12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12185-016-1974-6","volume":"103","author":"W Langeberg","year":"2016","unstructured":"Langeberg W, Schoonen W, Eisen M et al (2016) Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies. Int J Hematol 103:655\u2013664","journal-title":"Int J Hematol"},{"key":"1577_CR13","first-page":"185","volume":"3","author":"S Takagi","year":"2015","unstructured":"Takagi S, Suzuki I, Watanbe S (2015) Risk of thromboembolism in patients with immune thrombocytopenia. J Hematol Thromb Dis 3:185","journal-title":"J Hematol Thromb Dis"},{"key":"1577_CR14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bjh.14412","volume":"175","author":"M \u00c1lvarez-Rom\u00e1n","year":"2016","unstructured":"\u00c1lvarez-Rom\u00e1n M, Fern\u00e1ndez-Bello I, Jim\u00e9nez-Yuste V et al (2016) Procoagulant profile in patients with immune thrombocytopenia. Br J Haematol 175:925\u2013934","journal-title":"Br J Haematol"},{"key":"1577_CR15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","volume":"175","author":"F Nimwegen van","year":"2015","unstructured":"van Nimwegen F, Schaapveld M, Janus C et al (2015) Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med 175:1007\u20131017","journal-title":"JAMA Intern Med"},{"key":"1577_CR16","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1001\/jama.290.21.2831","volume":"290","author":"M Hull","year":"2003","unstructured":"Hull M, Morris C, Pepine C, Mendenhall N (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290:2831\u20132837","journal-title":"JAMA"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-017-1577-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-017-1577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T02:22:15Z","timestamp":1603246935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-017-1577-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s11239-017-1577-y","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"type":"print","value":"0929-5305"},{"type":"electronic","value":"1573-742X"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}